5 min listen
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
ratings:
Length:
5 minutes
Released:
Jul 20, 2023
Format:
Podcast episode
Description
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.
Released:
Jul 20, 2023
Format:
Podcast episode
Titles in the series (99)
April 2, 2020 Issue Introduction by Neurology Today in 5